| Product NDC: | 42364-4501 |
| Proprietary Name: | Cystex |
| Non Proprietary Name: | Methenamine, Sodium Salicylate |
| Active Ingredient(s): | 162; 162.5 mg/1; mg/1 & nbsp; Methenamine, Sodium Salicylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 42364-4501 |
| Labeler Name: | DSE Healthcare Solutions, LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20120401 |
| Package NDC: | 42364-4501-2 |
| Package Description: | 100 TABLET in 1 BOTTLE (42364-4501-2) |
| NDC Code | 42364-4501-2 |
| Proprietary Name | Cystex |
| Package Description | 100 TABLET in 1 BOTTLE (42364-4501-2) |
| Product NDC | 42364-4501 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Methenamine, Sodium Salicylate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120401 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | DSE Healthcare Solutions, LLC |
| Substance Name | METHENAMINE; SODIUM SALICYLATE |
| Strength Number | 162; 162.5 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |